Skip to main content

Table 2 Results of the long-rank test showing in detail the cumulative proportion of survivors, number of deaths and patients at risk in each group at the different follow-up time points

From: Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy – a single-centre experience

Responder to IS Follow-up (months) Cumulative proportion of survivors Number of cumulative deaths Number of patients at risk
1 4 0.94 1 17
2 5 0.89 2 16
3 6 0.83 3 15
4 7.7 0.78 5 14
5 9.1 0.72 6 13
6 10.0 0.67 7 12
7 13.0 0.61 8 11
8 20.2 0.56 9 10
9 27.4 0.5 9 9
10 27.7 - 9 8
11 45.0 - 9 7
12 48.3 - 9 6
13 48.9 0.42 10 5
14 49.6 0.33 11 4
15 51.7 - 11 3
16 52.6 -- 11 2
17 65.6 - 11 1
18 67.4 - 11 0
Non-Responder to IS     
1 7.0 0.83 1 5
2 11.0 0.67 2 4
3 11.9 0.5 3 3
4 12.9 0.33 4 2
5 16.0 0.17 5 1
6 47.0 0 6 0